Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune ...
In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...
Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune response against parasites ...